Official Publications OSE Immunotherapeutics

Equities

Real-time Euronext Paris Other stock markets 09:24:02 21/05/2024 BST			5-day change	1st Jan Change
7.17 ^EUR	-0.28%		-0.69%	+67.52%

04-17	OSE: licensing agreement with AbbVie enters into force	CF
04-17	OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie	MT

Monthly statement on voting rights	27/02/23	CO
Monthly statement on voting rights	30/01/23	CO
Monthly statement on voting rights	30/12/22	CO
Monthly statement on voting rights	29/11/22	CO
Monthly statement on voting rights	30/10/22	CO
Monthly statement on voting rights	29/09/22	CO
1st-half-year results	21/09/22	CO
1st-half-year results	21/09/22	CO
Half-year report	21/09/22	CO
Monthly statement on voting rights	30/08/22	CO
Changes in management and corporate officers	12/07/22	CO
Monthly statement on voting rights	29/06/22	CO
Monthly statement on voting rights	30/05/22	CO
Monthly statement on voting rights	29/04/22	CO
Monthly statement on voting rights	30/03/22	CO
Monthly statement on voting rights	27/02/22	CO
Monthly statement on voting rights	30/01/22	CO